Experts discuss the use of Simple Plex immunoassays on Ella to monitor the cellular immune response to SARS-CoV-2 in real time.

Ella enables the rapid and high quality cytokine and pro inflammatory biomarker monitoring in support of disease severity and progression research in a multi-analyte, automated and standardized format.

Carmen Cámara Hijón, PhD – Usefulness of Cytokine Measurement to Support Decision-Making in Patients with COVID-19

The correct characterization of the immune response induced by SARS-Cov-2 includes the pattern of cytokines in peripheral blood. Dr. Carmen Camara discusses how assaying cytokine profiles allows us not only to establish a cause-effect relationship in unusual conditions (e.g. chiblain lesions and COVID-19) but even to make therapeutic decisions in some of them (e.g. pediatric multisystemic inflammatory syndrome).

She also describes a fast and cost-efficient method of measuring the cellular response induced by vaccines by measuring IFN-γ and IL-2 after whole-blood overnight stimulation with SARS-CoV-2 peptides, to identify the correlate of immunity in patients at risk, such as those with primary immunodeficiencies.

Martina Fabris, MD – Cytokines and COVID-19: The Value in Risk Stratification Within the First 72 Hours of Hospitalization

It is increasingly clear that the immune response to COVID-19, and not the pathogen itself, is responsible for the exaggerated release of inflammatory molecules during infection. Several cytokines play a key role in SARS-CoV-2 pathogenesis and can help to identify patients with worse prognosis or in a different phase of the pathological process. However, these cytokines can be difficult to assay, and we do not yet understand their relationship with classic inflammatory markers like CRP.

Dr. Martina Fabris discusses which cytokines, alongside standard markers of systemic inflammation, are most valuable in identifying patients at a high risk of an unfavorable outcome, and on the other hand, low-risk patients who can reasonably be discharged from the hospital. She also describes the challenge of using these new biomarkers effectively in daily clinical practice to support complicated diagnoses, to evaluate risk more effectively, and to ensure increasingly targeted therapies.

DISCLAIMER:  The Ella™ automated immunoassay platform is currently offered for research use only; not for use in diagnostic procedures.

Resources

To retrieve a PDF copy of the presentation, click on the link below the slide player. From this page, click on the “Download” link to retrieve the file.

Presenters

Clinical Immunologist
Unidad de Inmunología
Hospital Universitario La Paz

As a clinical immunologist, Dr. Carmen Cámara Hijón's work is based on the diagnosis and treatment of primary immunodeficiencies. Her main research interests have been the implementation of new diagnostic techniques in immune-mediated diseases and the search for biomarkers to guide appropriate treatment with immunomodulators.

Medical Doctor
Diagnostics of Autoimmune Diseases
University of Udine (UNIUD)

Dr. Martina Fabris is head of the Immunopathology Laboratory of the University Hospital of Udine, which is a regional reference center for the diagnosis of systemic and neurological autoimmune diseases. Due to the COVID-19 pandemic, the Laboratory has been able to equip itself with new technologies and markers that now significantly support classical laboratory diagnostics and allow new ideas for research and targeted therapy.

Production Partner

Bio-Techne

Bio-Techne is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Our product portfolio, which represents the world-class brands of R&D Systems, Novus Biologicals, Tocris, ProteinSimple, ACD and Exosome Diagnostics, assists researchers with their scientific investigations into the functioning of the nervous systems, and the nature and progress of neurological diseases and disorders. We are a full-solution reagent and services provider, and our products, which are built for both reproducibility and compatibility, while harnessing the power of our leading-edge technology, can help advance your neuroscience research.

Related Content